Mena et al., 2020 - Google Patents
A droplet-based microfluidic viscometer for the measurement of blood coagulationMena et al., 2020
View HTML- Document ID
- 6451846321103479439
- Author
- Mena S
- Li Y
- McCormick J
- McCracken B
- Colmenero C
- Ward K
- Burns M
- Publication year
- Publication venue
- Biomicrofluidics
External Links
Snippet
A continuous microfluidic viscometer is used to measure blood coagulation. The viscometer operates by flowing oil and blood into a cross section where droplets are generated. At a set pressure, the length of the droplets is inversely proportional to the viscosity of the blood …
- 238000005259 measurement 0 title abstract description 21
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
- G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/86—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving blood coagulating time or factors, or their receptors
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
- G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
- G01N33/483—Physical analysis of biological material
- G01N33/487—Physical analysis of biological material of liquid biological material
- G01N33/49—Blood
- G01N33/4905—Determining clotting time of blood
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
- G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N11/00—Investigating flow properties of materials, e.g. viscosity, plasticity; Analysing materials by determining flow properties
- G01N11/02—Investigating flow properties of materials, e.g. viscosity, plasticity; Analysing materials by determining flow properties by measuring flow of the material
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Mena et al. | A droplet-based microfluidic viscometer for the measurement of blood coagulation | |
Karon | Why is everyone so excited about thromboelastrography (TEG)? | |
US9562914B2 (en) | Microfluidic device for real-time clinical monitoring and quantitative assessment of whole blood coagulation | |
JP4725819B2 (en) | System, method and computer-implemented process for analyzing coagulation of a fluid sample | |
Lehmann et al. | On-chip recalcification of citrated whole blood using a microfluidic herringbone mixer | |
Selby | “TEG talk”: expanding clinical roles for thromboelastography and rotational thromboelastometry | |
Prisco et al. | Point-of-care testing of hemostasis in cardiac surgery | |
JP2016503161A (en) | Centrifugal force microfluidic platelet complex function and drug reaction test apparatus and method | |
BR112017004506B1 (en) | ASSAY MICROCHIP FOR MEASUREMENT OF COAGULATION IN A BLOOD OR PLASMA SAMPLE, MICROASSAY DEVICE FOR MEASUREMENT OF COAGULATION IN A BLOOD OR PLASMA SAMPLE FROM AN INDIVIDUAL AND METHOD FOR MEASUREMENT OF COAGULATION TIME | |
JP7070641B2 (en) | Platelet agglutination ability analyzer, platelet agglutination ability analysis system, platelet agglutination ability analysis program and platelet agglutination ability analysis method | |
Guler et al. | Self-powered disposable prothrombin time measurement device with an integrated effervescent pump | |
Chen et al. | Point-of-care blood coagulation assay based on dynamic monitoring of blood viscosity using droplet microfluidics | |
Hyatt et al. | Point of care assessment of coagulation | |
WO2018128002A1 (en) | Blood-coagulation-system analyzer, blood-coagulation-system analysis system, blood-coagulation-system analysis method, blood-coagulation-system analysis program, hemorrhage-volume predictor, hemorrhage-volume prediction system, hemorrhage-volume prediction method, and hemorrhage-volume prediction program | |
Rossi et al. | Scalable manufacture of a disposable, storage-stable eight-channel microfluidic device for rapid testing of platelet, coagulation, and drug function under whole blood flow | |
Holt et al. | Quasi‐static acoustic tweezing thromboelastometry | |
US11998911B2 (en) | Microfluidic thromboelastometry instrument | |
Yu et al. | Real-time measurement of thrombin generation using continuous droplet microfluidics | |
Silverberg et al. | Comparison of citrated and fresh whole blood for viscoelastic coagulation testing during elective neurosurgery | |
MacIvor et al. | 27 How do we integrate thromboelastography with perioperative transfusion management? _3728 1386.. 1392 | |
Shiraishi et al. | Hemolysis and von Willebrand factor degradation in mechanical shuttle shear flow tester | |
Lin et al. | Comparing a piezoelectric quartz crystal with an optical coagulometer in monitoring high-dose heparin therapy by determining whole blood activated partial thromboplastin time and activated clotting time | |
Kang | Simultaneous measurement method of erythrocyte sedimentation rate and erythrocyte deformability in resource-limited settings | |
US20210354135A1 (en) | Systems and methods for evaluating an ability of a blood sample to coagulate, clot, and/or occlude | |
JP6750443B2 (en) | Platelet aggregation analysis method, platelet aggregation analysis device, platelet aggregation analysis program, and platelet aggregation analysis system |